|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| C07K 16/32 | |||
| A61P 35/00 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2943508 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14700281.0 |
| Europos patento paraiškos padavimo data | 2014-01-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2014/050344 |
| Data | 2014-01-10 |
| (87) | Numeris | WO 2014/108484 |
| Data | 2014-07-17 |
| (30) | Numeris | Data | Šalis |
| 13151076 | 2013-01-11 | EP |
| (72) |
BAUSS, Frieder, DE
BOSSENMAIER, Birgit, DE
FRIESS, Thomas, DE
GERDES, Christian, AR
HASMANN, Max, DE
THOMAS, Marlene, DE
WEISSER, Martin, DE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMBINATION THERAPY OF ANTI-HER3 AND ANTI-HER2 ANTIBODIES |
| COMBINATION THERAPY OF ANTI-HER3 AND ANTI-HER2 ANTIBODIES |